Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Probenecid induced immune hemolytic anemia.

T S Kickler, S Buck, P Ness

    The Journal of Rheumatology
    |February 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Survival outcomes and the role of DNADX ctDNA testing in patients treated with sacituzumab govitecan for metastatic breast cancer.

    ESMO open·2025
    Same author

    Re: Letter to the Editor of Public Health in response to 'Links between alcohol and external causes of deaths in males: an autopsy study'.

    Public health·2022
    Same author

    Links between alcohol and external causes of deaths in males: an autopsy study.

    Public health·2022
    Same author

    A novel diagnostic algorithm for heparin-induced thrombocytopenia.

    International journal of laboratory hematology·2018
    Same author

    Fostering reproducibility in industry-academia research.

    Science (New York, N.Y.)·2017
    Same author

    Modeling alloantibody formation to high-incidence red blood cell antigens in immune responders using genotypic data.

    Immunohematology·2017

    Probenecid, used for gout, can cause severe hemolytic anemia and rash. This immune-mediated reaction involves a specific antibody against probenecid.

    Area of Science:

    • Pharmacology
    • Hematology
    • Immunology

    Background:

    • Gouty arthritis is commonly treated with medications like probenecid and colchicine.
    • Adverse drug reactions can manifest in various ways, including hematologic complications.

    Observation:

    • A patient developed severe hemolytic anemia and a generalized rash during treatment for acute gouty arthritis.
    • The patient was concurrently receiving probenecid and colchicine therapy.

    Findings:

    • Hemolytic anemia was confirmed to be immune-mediated, indicated by a positive direct Coombs' test.
    • In vitro studies identified a specific antibody dependent on probenecid, confirming its role in the reaction.

    Implications:

    • This case highlights a rare but serious adverse effect of probenecid.

    Related Experiment Videos

  • Awareness of this potential drug-induced hemolytic anemia is crucial for clinicians managing gout patients.
  • Further investigation into drug-antibody interactions in adverse hematologic events is warranted.